| Prev Close: | 11.75 |
|---|---|
| Open: | 11.80 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | N/A |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 11.40 - 11.80 |
|---|---|
| 52wk Range: | 10.00 - 17.00 |
| Volume: | 13,496 |
| Avg Vol (3m): | 3,822 |
| Market Cap: | 50.07M |
| P/E (ttm): | N/A |
| EPS (ttm): | -7.99 |
| Div & Yield: | N/A (N/A) |
Headlines
- Cancer Genetics to Attend ASCO Annual MeetingBusiness Wire(Mon 5:38PM EDT)
- RedChip TV Announces Guest Lineup for This Week's "RedChip Money Report"GlobeNewswire(Fri, May 17)
- CANCER GENETICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhiEDGAR Online(Wed, May 15)
- Cancer Genetics Announces First Quarter 2013 Financial Results and Significant Business and Portfolio ProgressBusiness Wire(Wed, May 15)
- CANCER GENETICS, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- Cancer Genetics to Sponsor and Host Roundtable at BioNJ Diagnostics & Personalized Medicine Innovation SummitBusiness Wire(Tue, May 14)
- Cancer Genetics Announces Conference Call to Discuss First Quarter ResultsBusiness Wire(Fri, May 10)
- Cancer Genetics Announces Distribution Partnership with Nikon InstrumentsBusiness Wire(Wed, May 8)
- Cancer Genetics to Present at UBS Global Healthcare ConferenceBusiness Wire(Mon, May 6)
- Cancer Genetics Launches Proprietary Microarray for Kidney CancerBusiness Wire(Thu, May 2)
- Cancer Genetics, Inc. Announces Closing of Initial Public Offering of 690,000 Shares of Common StockBusiness Wire(Wed, Apr 10)
- Cancer Genetics, Inc. Announces Full Exercise of Over-Allotment OptionBusiness Wire(Fri, Apr 5)
- U.S. IPO Weekly Recap: Calendar Quickly Builds, Silver Spring Jumps In Debutat Seeking Alpha(Tue, Mar 19)
Press Releases
- Cancer Genetics to Attend ASCO Annual MeetingBusiness Wire(Mon 5:38PM EDT)
- RedChip TV Announces Guest Lineup for This Week's "RedChip Money Report"GlobeNewswire(Fri, May 17)
Reports
- No Reports available for CGIX at this time.
